Evidence map›Paper›PMID 40950100›Full record

ArticlebioRxiv : the preprint server for biology2025

Frequency-selective contrast sensitivity modulation driven by fine-tuned exogenous attention at the foveal scale.

Yue Guzhang, T Florian Jaeger, Martina Poletti

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Yue GuzhangDepartment of Brain and Cognitive Sciences, University of Rochester, Rochester, NY, United States.ORCID 0009-0008-6637-2284
T Florian JaegerDepartment of Brain and Cognitive Sciences, University of Rochester, Rochester, NY, United States.
Martina PolettiDepartment of Brain and Cognitive Sciences, University of Rochester, Rochester, NY, United States.ORCID 0000-0002-4773-8745

Funding

VISUAL SCIENCE RESEARCH CTR SUPPORTP30EY001319 · NEI · UNIVERSITY OF ROCHESTER · PI Susana Marcos · 1985 to 2026
$17.5M
Vision, Attention and Eye Movements at the Scale of the FoveolaR01EY029788 · NEI · UNIVERSITY OF ROCHESTER · PI Martina Poletti · 2019 to 2026
$3.4M
NEI NIH HHS P30 EY001319NEI NIH HHS R01 EY029788
6 · The paper itself

Abstract

Exogenous attention is a rapid, involuntary mechanism that automatically reallocates processing resources toward salient stimuli. It enhances visual sensitivity in the vicinity of the salient stimulus, both in extrafoveal regions and within the high-acuity foveola. While the spatial frequencies modulated by exogenous attention in extrafoveal vision are well characterized, it remains unknown how this mechanism operates within the foveola, which can resolve spatial frequencies up to 30 cycles per degree (CPD). Here, we examined which spatial frequencies were enhanced by fine-grained deployments of exogenous attention within this highest-acuity region of the visual field. Using high-precision eye-tracking and gaze-contingent display control to precisely localize gaze during attentional allocation, we found that exogenous attention at the foveal scale selectively enhances contrast sensitivity for low- to mid-range spatial frequencies (4-8 CPD), with no significant benefits for higher spatial frequencies (12-20 CPD). In contrast, attention-related benefits on asymptotic performance at the highest contrast were observed across a wide range of spatial frequencies. These results indicate that, despite the high-resolution capacity of the foveola, exogenous attention remains an inflexible mechanism that, even at this scale, selectively enhances contrast gain for lower spatial frequencies-mirroring its behavior in extrafoveal vision.

Identifiers

PMID40950100
PMCPMC12424650

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.